Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The FDA approved Sublocade, Indivior's once-monthly buprenophine injection, to treat opioid use disorder in adults with moderate-to-severe addiction.
Here are the four latest drugs or medical devices approved by the FDA since Nov. 17.
The FDA approved Foundation Medicine's cancer gene test Thursday. CMS also proposed national coverage of the test for Medicare beneficiaries with advanced cancer.
A national saline bag shortage related to manufacturing delays in Puerto Rico most captured readers' attention in November.
Amazon has reportedly held preliminary discussions with several generic drug manufacturers regarding the company's potential foray into the pharmacy business, sources familiar with the matter told CNBC.
Though texting prescription orders has become common in many organizations, a new survey from the Institute for Safe Medication Practices found 33 percent of hospital workers oppose the practice, according to Pharmacy Practice News.
Atenolol, a beta blocker used to treat high blood pressure, chest pain and heart attacks, has been in short supply since July.
Here are six articles Becker's Hospital Review published in the last week, featuring a look at the Drug Enforcement Agency's mandate to decrease opioid production by 20 percent in 2018 and CVS Health's "real-time benefits" tool to boost drug price transparency.
The FDA recently cleared AliveCor's electrocardiogram accessory for the Apple Watch, the Mountain View, Calif.-based company announced Nov. 30.
About 10 percent of medical products in the world's poorest countries are either counterfeits or do not meet quality requirements, according to research from the World Health Organization.